Literature DB >> 17533366

Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.

J Pecha1, D Ankrapp, C Jiang, W Tang, I Hoshino, K Bruck, K-U Wagner, H Xiao.   

Abstract

Transformation of mammary epithelial cells (MECs) from the normal to the neoplastic stage requires the dysregulation of tumor suppressor genes and proto-oncogenes. Tip30 is a tumor suppressor that can inhibit estrogen receptor-mediated transcription in MECs, but its role in MEC proliferation remains unknown. Here, we show that deleting the Tip30 gene leads to ductal hyperplasia in mouse mammary glands early in life and extensive mammary hyperplasia with age. Tip30(-/-) mammary glands transplanted into wild-type mammary fat pads also display mammary trees with extensive ductal hyperplasia. Strikingly, Tip30 deletion promotes proliferation of primary MECs and results in rapid immortalization of MECs in vitro relative to wild-type cells. Gene array analysis identified significant increases in the expression of mammary epithelial growth factors Wisp2 and Igf-1 in Tip30(-/-) cells. Knockdown of either Wisp2 or Igf-1 using short interfering RNA dramatically inhibited proliferation of Tip30(-/-) cells. Together, these results suggest that Tip30 is an intrinsic and negative regulator of MEC proliferation partly through the inhibition of Wisp2 and Igf-1 expression, and its absence in the mammary gland may predispose MECs to neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533366     DOI: 10.1038/sj.onc.1210548

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  CCN5: biology and pathophysiology.

Authors:  Joshua W Russo; John J Castellot
Journal:  J Cell Commun Signal       Date:  2010-09-21       Impact factor: 5.782

2.  Clinicopathologic significance and survival of TIP30 expression in laryngeal squamous cell carcinoma.

Authors:  Jianqiu Chen; Chunsheng Zhu; Minhui Zhu; Ming Geng; Yongsheng Tian; Guojun Li; Hongliang Zheng
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.

Authors:  Chengliang Zhang; Mikito Mori; Shenglan Gao; Aimin Li; Isamu Hoshino; Mark D Aupperlee; Sandra Z Haslam; Hua Xiao
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

4.  CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation.

Authors:  Vivian Chen; Emma Shtivelman
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

Review 5.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

6.  CC3/TIP30 affects DNA damage repair.

Authors:  Sylvia Fong; Frank King; Emma Shtivelman
Journal:  BMC Cell Biol       Date:  2010-04-07       Impact factor: 4.241

7.  Decreased TIP30 expression promotes tumor metastasis in lung cancer.

Authors:  Xin Tong; Kai Li; Zhigang Luo; Bin Lu; Xing Liu; Tao Wang; Mingshu Pang; Beibei Liang; Min Tan; Mengchao Wu; Jian Zhao; Yajun Guo
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

8.  TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice.

Authors:  A Li; C Zhang; S Gao; F Chen; C Yang; R Luo; H Xiao
Journal:  Oncogene       Date:  2012-06-25       Impact factor: 9.867

9.  Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.

Authors:  F Chen; A Li; S Gao; D Hollern; M Williams; F Liu; E A VanSickle; E Andrechek; C Zhang; C Yang; R Luo; H Xiao
Journal:  Cell Death Dis       Date:  2014-05-22       Impact factor: 8.469

10.  Contribution of TIP30 to chemoresistance in laryngeal carcinoma.

Authors:  M Zhu; F Yin; L Yang; S Chen; R Chen; X Zhou; W Jing; X Fan; R Jia; H Wang; H Zheng; J Zhao; Y Guo
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.